Welcome to the SOM Clinical Research Glossary
Quickly look up the meaning of words, acronyms, or abbreviations commonly used in clinical research:
- Narrow your search by typing the word you are looking for in the search box. Clear the search box to start a new search.
- Use the alphabet bar for quick filtering of words by first letter or select a word category to explore words that are related. Remove the letter or word filters by clicking the respective ALL button.
Return to the glossary index page after each word search using the « Back to Glossary Index link.
- Adverse Drug Reaction (ADR)
- Adverse Event (AE)
- Adverse Reaction (AR)
- Age of majority
- AIR (Activities Interests and Relationships)
- ALCOA (Attributable, Legible, Contemporaneous, Original, Accurate)
- ALCOA Plus, ALCOA+
- ALICE
- Ancillary review
- Applicable Clinical Trial (ACT)
- Applicable regulatory requirements
- Approved drug
- Arm
- Aspirational benefit
- Assent
- Assessment
- Association for Clinical and Translational Science (ACTS)
- Association for the Accreditation of Human Research Protection Programs (AAHRPP)
- Association of Clinical Research Professionals (ACRP)
- Attrition
- Audit
- Audit report
- Audit trail
- Award
- Baseline
- Baseline assessment
- Benefit
- Bias
- Billing Coverage Analysis (BCA)
- Biobank
- Biologic
- Biological Product
- Biological specimen
- Biologics License Application (BLA)
- Biomedical Research Imaging Center (BRIC)
- Biospecimen
- Biospecimen Processing Facility (BSP)
- Blinding
- BLUE
- Breach of confidentiality
- Budget
- Budget justification
- Budget period
- Budget revision
- Business Associate
- Business Associate Agreement (BAA)
- Carolina Data Warehouse for Health (CDW-H)
- Case Report Form (CRF)
- Causality
- Cayuse
- Ceded review
- Centers for Disease Control and Prevention (CDC)
- Centers for Medicare & Medicaid Services (CMS)
- Centralized monitoring
- Certificate of Confidentiality (CoC)
- Certified copy
- Child
- Clinical and Translational Research Center (CTRC)
- Clinical and Translational Science Awards (CTSA) Program
- Clinical development
- Clinical investigation
- Clinical monitor
- Clinical research
- Clinical Research Accountability Unit (CRAU)
- Clinical Research Associate (CRA)
- Clinical Research Coordinator (CRC)
- Clinical Research Management System (CRMS)
- Clinical Research Support Office (CRSO)
- Clinical significance
- Clinical study
- Clinical trial
- Clinical Trial Agreement (CTA)
- ClinicalTrials.gov
- Clinical Trials Quality Assurance (CTQA) Program
- Coded
- Code of Federal Regulations (CFR)
- Cohort
- Co-investigator
- Collaborative Institutional Training Initiative (CITI)
- Collateral benefit
- Commercial Institutional Review Board (IRB)
- Common data model
- Common Rule
- Common Terminology Criteria for Adverse Events (CTCAE)
- Compensation
- Competitive Renewal
- Complaint
- Compliance
- Computable Phenotype
- Concomitant medication
- Confidential Disclosure Agreement (CDA)
- Confidentiality
- Conflict of Interest (COI)
- Conflict of Interest Office
- Consent capacity
- Continuing noncompliance
- Continuing review
- Contract
- Contract Research Organization (CRO)
- Control group
- Coordinating Center (CC)
- Corrective and Preventive Action (CAPA) Plan
- Data
- Data acquisition
- Data and Safety Monitoring Board (DSMB)
- Data and Safety Monitoring Committee (DSMC)
- Data and Safety Monitoring Plan (DSMP)
- Database
- Database Management System (DBMS)
- Data encryption
- Data entry
- Data Integrity
- Data management
- Data Management and Sharing Plan (DMS Plan)
- Data Management Plan (DMP)
- Data Management System (DMS)
- Data Monitoring Committee (DMC)
- Data Use Agreement (DUA)
- Deferral
- Delegation of Authority (DOA) Log
- Demographic data
- Department of Health and Human Services (DHHS)
- Direct benefit
- Disapproval
- Discontinue
- Disease registry
- Dosage regimen
- Dose Limiting Toxicity (DLT)
- Double blinding
- Drug
- Drug toxicity
- ECRT (Effort Certification and Reporting Technology)
- Efficacy
- Effort
- Electronic Case Report Form (eCRF)
- Electronic Data Capture (EDC)
- Electronic Health Record (EHR)
- Electronic Informed Consent (eIC)
- Electronic Medical Record (EMR)
- Elements of informed consent
- Eligibility criteria
- Embryonic Stem Cell Research Oversight (ESCRO) Committee
- Encounter
- Encounter Level Data
- Encryption
- Endpoint
- Engaged
- Enrolled
- Enrollment
- Environment, Health and Safety (EHS)
- Epic
- Essential document
- Exclusion criteria
- Exculpatory language
- Exempt review
- Expanded access
- Expedited review
- Experimental drug
- Experimental group
- Export Compliance Office
- Export control
- Fabrication
- Falsification
- Family Educational Rights and Privacy Act (FERPA)
- FDA Form 482
- FDA Form 483
- FDA Form 1571
- FDA Form 1572
- Feasibility assessment
- Federalwide Assurance (FWA)
- Food and Drug Administration (FDA)
- Food, Drug and Cosmetics Act
- Free text data
- Full board review
- Funder
- Generalizability, Generalization
- Good Clinical Practice (GCP)
- Grant application
- Grant Number
- Greater than minimal risk
- Guardian
- GxP
- Health literacy
- Healthy volunteer
- HIPAA authorization
- HIPAA covered entity
- HIPAA (Health Insurance Portability and Accountability Act)
- HIPAA Privacy Rule
- Humanitarian Device Exemption (HDE)
- Humanitarian Use Device (HUD)
- Human Research Protection Program (HRPP)
- Human subject
- Human Subjects Research (HSR)
- Hypothesis
- Identifiable biospecimen
- Identifiable private information
- Identifier
- Impartial witness
- Inclusion criteria
- Inclusion/Exclusion (I/E) criteria
- Independent Ethics Committee (IEC)
- Independent IRB
- Indication
- Indirect benefit
- Indirect Facility & Administrative (F&A) costs
- Individual Conflict of Interest (COI)
- Industry
- Industry Contracting (IC)
- Industry sponsored study
- Informed Consent Form (ICF)
- Inspection
- Institution
- Institutional Biosafety Committee (IBC)
- Institutional Conflict of Interest (COI)
- Institutional Integrity and Risk Management (IIRM)
- Institutional Official (IO)
- Institutional Privacy Office (IPO)
- Institutional Privacy Officer
- Institutional Review Board Information System (IRBIS)
- Institutional Review Board (IRB)
- Interaction
- International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9CM)
- International Council for Harmonisation (ICH)
- Intervention
- Interventional study
- Investigation
- Investigational device
- Investigational Device Exemption (IDE)
- Investigational drug
- Investigational Drug Service (IDS)
- Investigational New Drug (IND)
- Investigational New Drug (IND) safety report
- Investigational plan
- Investigational product (IP)
- Investigator
- Investigator agreement
- Investigator-initiated study
- Investigator's Brochure (IB)
- In vitro
- In vivo
- IRB application
- IRB approval
- IRB Authorization Agreement (IAA)
- IRB expiration
- IRB of record
- Just-in-Time (JIT)
- Key information
- Label
- Labeling
- Legally Authorized Representative (LAR)
- Legally effective informed consent
- Letter of intent
- Life-threatening adverse event
- Limited dataset
- Lineberger Comprehensive Cancer Center (LCCC)
- Local considerations
- Long form
- Longitudinal study
- Long Term Follow-Up (LTFU)
- Lost to Follow Up (LTFU)
- Manual of procedures (MOP)
- Material transfer agreement (MTA)
- Medical device
- Medical monitor
- Medical record
- Medical Record Number (MRN)
- Memorandum of understanding (MOU)
- Minimal risk
- Minor
- Monitor
- Monitoring
- Monitoring plan
- Monitoring report
- Multicenter study
- Multisite study
- National Institutes of Health (NIH)
- New Drug Application (NDA)
- NIH National Library of Medicine (NLM)
- NIH Public Access Policy
- No Cost Extension (NCE)
- Nonclinical study
- Noncompliance
- Nondisclosure agreement (NDA)
- Nonsignificant Risk (NSR) medical device
- Nonsignificant Risk (NSR) medical device study
- North Carolina Translational and Clinical Sciences (NC TraCS) Institute
- Not Human Subjects Research (NHSR)
- Notice of Award (NOA)
- Notice of privacy practices
- Not reasonably available (as it applies to locating a parent)
- Observational study
- Observational Study Monitoring Board (OSMB)
- Office for Human Research Protections (OHRP)
- Office for Innovation, Entrepreneurship and Economic Development (IEED)
- Office of Clinical Trials (OCT)
- Office of Human Research Ethics (OHRE)
- Office of Research Communications (ORC)
- Office of Research Development (ORD)
- Office of Research Information Systems (ORIS)
- Office of Research (OoR)
- Office of Research Support and Compliance (ORSC)
- Office of Sponsored Research (OSR)
- Office of Technology Commercialization (OTC)
- Office of the Vice Chancellor for Research (OVCR)
- Office of University Counsel (OUC)
- Off-label use
- On-site monitoring
- Open-label trial
- Organizational Conflict of Interest (COI)
- Outcome
- Package insert
- Parent
- Parental permission
- Part 11
- Participant
- Participant engagement
- Participant partners
- Participating site
- Patient Centered Outcomes Research Network (PCORnet)
- Patient level data
- Patient registry
- Personnel Profile and Training System (PaTS)
- Pharmacogenomics
- Pharmacokinetics (PK)
- Phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- Placebo
- Placebo effect
- Plagiarism
- Plain language
- Possibly related to the research
- Pragmatic trial
- Preclinical research
- Principal Investigator (PI)
- Privacy
- Privacy board
- Privacy Rule
- Private information
- Procedure
- Program announcement
- Program officer
- Promptly Reportable Information (PRI)
- Prospective study
- Protected Health Information (PHI)
- Protocol
- Protocol amendment
- Protocol deviation
- Protocol Review Committee (PRC)
- PubMed Central (PMC)
- Quality Assurance (QA)
- Quality Control (QC)
- Quality Improvement (QI)
- Query
- Questionnaire
- Quorum
- Radiation Safety Committee (RSC)
- Radiation Safety Subcommittee (RSS)
- Radioactive Drug Research Committee (RDRC)
- RAMSeS (Research Administration Management System & electronic Submission)
- Randomization
- Randomized
- Reasonable possibility
- Recruitment
- Recruitment period
- Recruitment plan
- Recruitment status
- REDCap (Research Electronic Data Capture)
- Registry study
- Regulatory binder
- Reliance agreement
- Relying Institution
- Repository
- Research
- Research administrator
- Research Compliance Program (RCP)
- Research Coordination & Management Unit (RCMU)
- Researcher
- Research misconduct
- Research personnel
- Research plan
- Research registry
- Research study
- Research team
- Research team members
- Responsible conduct of research
- Retention
- Retention plan
- Retrospective study
- Reviewing IRB
- Reviewing IRB Institution
- Rights
- Risk
- Risk-based monitoring
- Root cause
- Root Cause Analysis (RCA)
- Safety
- Safety and Security Committee
- Schedule of activities (SOA)
- Schedule of Assessments
- School of Medicine (SOM)
- Scientific Review Committee (SRC)
- Screen failure
- Screening
- Screening log
- Sensitive Information (SI)
- Serious Adverse Event (SAE)
- Serious and Unexpected Suspected Adverse Reaction (SUSAR)
- Serious noncompliance
- Severity
- Short form
- Short form consent
- Side effects
- Significant Risk (SR) medical device
- Significant Risk (SR) medical device study
- Single blinding
- Single IRB (sIRB)
- Site Initiation Visit (SIV)
- Site investigator
- Site Master File (SMF)
- SMART IRB
- Society of Clinical Research Associates (SoCRA)
- SOM Conflict of Interest Committee (COIC)
- Source data
- Source documents
- Sponsor
- Sponsored Program Office (SPO)
- Sponsored Research Agreement (SRA)
- Sponsor-investigator
- Standard of Care (SOC)
- Standard Operating Procedure (SOP)
- Stopping rules
- Stratification
- Structured data
- Study
- Study Coordinator (SC)
- Study design
- Study documentation
- Study monitor
- Study population
- Study site
- Sub-investigator
- Subject
- Subject binder
- Subject chart
- Subject identification number/code
- Suspected Adverse Reaction
- Suspension
- Target enrollment
- Termination
- Test article
- Therapeutic misconception
- Tolerability
- Toxicity
- Trial
- Trial Master File (TMF)
- Unanticipated Adverse Device Effect (UADE)
- Unanticipated Problem Involving Risk to Subjects or Others (UPIRSO)
- UNC Health
- UNC Health Network Entities
- UNC Health Privacy Office
- Underserved population
- Unexpected adverse event
- University of North Carolina at Chapel Hill
- Visit
- Volunteer
- Vulnerable populations
- Washout Period
- Welfare
- Well-being
- Work Instruction (WI)
- Written
We appreciate your input!
Let us know if there is a clinical research term that you would like us to add or clarify: